Removal of gallbladder can cause trouble with fat digestion, constipation or even diarrhoea, but these are all temporary side ...

The California Privacy Protection Agency (CalPrivacy) has taken action against the Datamasters marketing firm that sold the ...

CG Oncology develops cretostimogene via rolling BLA, phase 3 PIVOT-006 data in 1H 2026, and $680M cash into 2028. Find out ...

I was living a normal 29-year-old life. I thought my symptoms were no big deal, until they started happening more ...

An update from the phase 2 LEGEND trial shows that the investigational nonviral gene therapy detalimogene voraplasmid has achieved a 62% complete response rate at six months in patients with high-risk ...

PIVOT-006 Phase 3 topline data evaluating cretostimogene monotherapy for intermediate-risk NMIBC now expected in 1H 2026, nearly one year ahead ...

A new database targeting chronic urinary tract infections (UTIs)—a long-overlooked condition that may begin in childhood—is ...

A new database targeting chronic urinary tract infections (UTIs) – a long-overlooked condition that may begin in childhood – ...

If you’re a pet parent you know it’s not always easy to bring your furry friend to the vet for care. Now, there’s a new ...

Doctors report school-age patients suffering irreversible urological harm as holiday binge culture and cheap access fuel the ...

Padcev is approved for use in combination with the programmed death 1 inhibitor Keytruda (pembrolizumab) or Keytruda QLEX (pembrolizumab and berahyaluronidase alfa-pmph) as neoadjuvant treatment and ...

For individuals facing fear, uncertainty and repeated procedures associated with recurrent low-grade intermediate-risk bladder tumors, timely access to treatment can be critical. ZUSDURI, the first ...